RESULTS: As demonstrated in Figure 1 for the validation cohort, there was a strong relationship between expected 24-hour urine creatinine based on lean body mass and the measured urinary creatinine (r 2 ¼0.7, p<0.01), which was stronger than the relationship between measured urinary creatinine and weight (r 2 ¼0.5, p<0.01). Using the traditional metric of Cr/Kg, 38% of patients in our cohort were considered to have an inadequate 24-hour urine collection (Figure 1a) , and there more dispersion among inadequate specimens. Using the regression model on the validation set (Figure 1b) , 15% of specimens were considered inadequate, and the majority were due to under collection.
INTRODUCTION AND OBJECTIVES:
Prior studies have demonstrated links between uric acid stone risk and low urine pH, visceral fat area (VFA) and the ratio of visceral to subcutaneous adipose tissue (VFA%). Our objective was to assess the association of CTbased visceral obesity with 24-hour urine metabolic risk factors stone composition in kidney stone formers (KSF) .
METHODS: This is a retrospective analysis of 99 kidney stone formers who had CT imaging and 24-hour urine studies at our institution. For each patient, a single axial area measurement was obtained at L3-4 in females and L2-3 in males for visceral fat area (VFA) and subcutaneous fat area (SFA). Percentage of visceral fat was calculated with the formula VFA%¼[VFA/(VFA+SFA)] X 100. From established data, a VFA > 186 cm 2 was considered elevated in terms of risk of nephrolithiasis. Patient demographics, serum chemistry, 24-hour urine parameters and stone composition were collected for each patient. Univariate analysis was performed to compare patients with normal and elevated VFA. Multivariate linear and logistic regression was performed to assess for variables associated with 24-hour urine parameters and stone composition.
RESULTS: Compared to patients with normal VFA, patients with high VFA were older (65 vs 51 yrs, p<0.0001), more obese (BMI 33.3 vs 28, p¼0 .02) and were male (70.7% vs 30%, p¼0.001). They also had higher prevalence of HTN (81% vs 45%, p<0.0001), DM (31% vs 12.5%, p¼0.003), CAD (32.8% vs 7.5%, p¼0.003 (Uox) has been correlated to increasing BMI. Our objectives were to determine if this association is linked to hemoglobin A1C levels (A1C).
METHODS: We retrospectively reviewed 1,428 twenty-four hour urine collections gathered from a single institution from 2004-2015 from two urologists. 665 unique non cystinuric adult stoneformers (SF) with complete data including BMI, age, gender, A1C levels, and Uox were then analyzed using ANOVA, Chi-squared, and linear regression analyses.
RESULTS: Average age of SF was 49.9 years. 46% of SF were female. Average BMI was 29.2 (Underweight 1.4%, Normal weight 26.5%, Overweight 35.8%, Obese 27.7%, Morbidly Obese 8.6%). Greater BMI correlated with increased Uox (mg/d) (p0.0001, r¼0.245) and remained significant for both males (p0.001, r¼0.30) and females (p0. 001, r¼0.195) . The positive correlation between BMI and Uox was also seen in both African American and Caucasian subjects (r¼0.34, p¼0.02 and r¼0.20, p0.005). A significant positive correlation between A1C and Uox was demonstrated (r¼0.24, p 0.009).
CONCLUSIONS: Among SFs, there is a positive correlation between BMI and Uox as well as A1C and Uox. These relationships may explain associations between both obesity and diabetes and the development of kidney stones.
Source of Funding: AUA Research Scholar

MP01-13 IS THERE A SHIFT FROM INFECTIOUS STONES IN STAGHORN CALCULI?
Tyler Haden*, Paige Kuhlmann, Jacqueline Ross, Stephen Kalkhoff, Carrie Johans, Alex Jones, Stephen Weinstein, Mark Wakefield, Daniel Hoyt, James Cummings, Naveen Pokala, Columbia, MO INTRODUCTION AND OBJECTIVES: Historically staghorn calculi have been thought of as infectious stones, made up primarily of magnesium ammonium phosphate or (struvite) stones. The American Urological Association (AUA) guidelines for management of staghorn calculi continue to state calcium oxalate or calcium phosphate stones as unlikely causes of staghorn calculi. We reviewed our institutions incidence of infectious and metabolic composition in large staghorn calculi METHODS: Medical records were retrospectively reviewed for patients who underwent percutaneous nephrolithotomy (PCNL) for complete staghorn calculus from 2010 to 2015. Stone analysis and charts were reviewed for demographics, surgical complications, preoperative urine results and outcomes compared to stone type. Primary outcome of the study was to identify stone composition in infectious and non-infectious cases Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e5 RESULTS: 217 PCNLs were completed at our institution between 2010-2015 for stones >2cm. 72 patients (75 kidneys) had large staghorn calculus that met our size criteria. 3 of these were excluded. Overall 28 (39%) of patients were found to have infection stones, either struvite or carbonate. 44(61%) stones were composed of metabolic based stones without any infectious composition. The primary compositions in the metabolic stone group were calcium phosphate (52%), Uric Acid (18%), calcium oxalate (18%), and cystine (12%). In patients with purely metabolic stones, 65% of patients with primarily calcium phosphate hydroxyapatite had positive pre-op urine cultures, while only 12.5% of patients with primary calcium oxalate stones had positive pre-op urine cultures. Preoperative urine cultures revealed Proteus present (4.5% vs 46.4%) for non-infectious and infectious stones. E. Coli was present in preoperative urine cultures (15.9% vs 3.5%) for non-infectious and infectious stones. Proteus was the most common bacteria in infectious stones, while E. Coli was most common with metabolic stones. Infectious stones were 3.2 times as likely to have at least a Clavien-Dindo Grade 1 complication as metabolic stones (p¼0.017).
CONCLUSIONS: In our study more staghorn calculus were composed of metabolic stones than infectious stones. Calcium phosphate was the most common stone composition for staghorn calculi differing from historical reports of staghorn calculi being primarily infectious. Patients with calcium phosphate stones also had a high rate of positive urine cultures. More research is needed on the cause of this paradigm shift.
Source of Funding: None
MP01-14 DO METABOLIC FACTORS INFLUENCE THE FORMATION AND RECURRENCE OF BLADDER CALCULI?
Julie Thai*, Tim Tran, Egor Parkhomenko, Mantu Gupta, New York, NY INTRODUCTION AND OBJECTIVES: Metabolic abnormalities are associated with an increased risk for renal calculi. However, no studies to date have investigated whether metabolic factors affect the formation or recurrence of adults with bladder calculi. We aim to characterize patients with primary bladder stones, with and without kidney stones, based on their clinical factors, 24-hour urine, and stone composition.
METHODS: We reviewed the medical records of patients with primary bladder stones and classified them based on their history of kidney stones, metabolic factors, clinical characteristics, and stone composition. We used descriptive statistics, multivariate analysis, and one-way ANOVA to look at associations between these parameters.
RESULTS: Final analysis included 50 men with mean age 64 years (range: 21 to 92). 90% of these patients had a history of concurrent kidney stones. Bladder stone only formers (N¼10) were older, and had greater total stone burden, higher stone recurrence rates (40% versus 25%), more metabolic abnormalities, and significantly lower urine pH (p ¼ 0.03) compared to the concomitant kidney stone formers (N¼40). Bladder stone only formers had a higher incidence of uric acid (UA) composition compared to their counterparts (62.5% versus 31.5%). Further, UA stones in the bladder demonstrated lower pH (p ¼ 0.02) while renal UA stones were associated with lower Cit24 (p ¼ 0.03). Stone concordance in the concomitant kidney stone group was 55.6%.
CONCLUSIONS: Primary bladder stone formers had surprisingly high rates of kidney stone formation and higher incidence of recurrence than has been previously reported. Duly, bladder stone formation may pose a risk for recurrence of bladder and/or kidney stones. The metabolic profiles of both groups, regardless of whether they made only bladder stones or both bladder and kidney stones, were similar. Aggressive treatment for outlet obstruction and metabolic abnormalities may be warranted in patients who are bladder stone only or concomitant kidney stone formers. knowledge of risk factors for nephrolithiasis may aid in developing prevention programs. We assessed patients 0 perceptions of dietary risk factors affecting kidney stone formation, and determined independent predictors of patient awareness of factors promoting stone disease.
METHODS: A 24-question survey assessing dietary knowledge of nephrolithiasis risk factors and demographic data was administered prospectively to 1,018 urology patients. Responses were summarized with frequency and percent. Statistical comparisons were made using chi-square tests. Multiple logistic regression was used to detect significant predictors of knowledge of stone disease risk.
RESULTS: The study cohort was comprised of 70% (n¼711) male patients; overall, only 25% (n¼259) of participants responded that diet had an effect on kidney stone development. A total of 28% (n¼284) reported a prior history of stone disease; of those respondents, 43% (n¼122) believed that diet does effect kidney stone formation. The majority of respondents (58.9%, n¼598) reported a willingness to make lifestyle changes aimed at lowering their stone risk. Participants who reported previous nephrolithiasis education were 35 CONCLUSIONS: Knowledge of dietary risk factors promoting nephrolithiasis was limited among our study population. However, the majority of patients expressed a willingness to make appropriate nutritional modifications. Respondents who received prior education on stone development appeared to be aware that diet affects the risk of kidney stone formation. Patients indicated that urologists typically deliver kidney stone related education. These results suggest a need for e6 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 
